DRGEM Corporation (263690) - Net Assets
Based on the latest financial reports, DRGEM Corporation (263690) has net assets worth ₩89.26 Billion KRW (≈ $60.49 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩119.28 Billion ≈ $80.83 Million USD) and total liabilities (₩30.02 Billion ≈ $20.34 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 263690 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩89.26 Billion |
| % of Total Assets | 74.83% |
| Annual Growth Rate | 30.43% |
| 5-Year Change | 64.94% |
| 10-Year Change | N/A |
| Growth Volatility | 26.85 |
DRGEM Corporation - Net Assets Trend (2015–2024)
This chart illustrates how DRGEM Corporation's net assets have evolved over time, based on quarterly financial data. Also explore DRGEM Corporation balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for DRGEM Corporation (2015–2024)
The table below shows the annual net assets of DRGEM Corporation from 2015 to 2024. For live valuation and market cap data, see 263690 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩86.65 Billion ≈ $58.72 Million |
+9.23% |
| 2023-12-31 | ₩79.32 Billion ≈ $53.75 Million |
+7.72% |
| 2022-12-31 | ₩73.63 Billion ≈ $49.90 Million |
+20.70% |
| 2021-12-31 | ₩61.01 Billion ≈ $41.34 Million |
+16.13% |
| 2020-12-31 | ₩52.53 Billion ≈ $35.60 Million |
+61.53% |
| 2019-12-31 | ₩32.52 Billion ≈ $22.04 Million |
+13.40% |
| 2018-12-31 | ₩28.68 Billion ≈ $19.43 Million |
+83.19% |
| 2017-12-31 | ₩15.65 Billion ≈ $10.61 Million |
+64.15% |
| 2016-12-31 | ₩9.54 Billion ≈ $6.46 Million |
+20.28% |
| 2015-12-31 | ₩7.93 Billion ≈ $5.37 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to DRGEM Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4616.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩70.72 Billion | 81.62% |
| Common Stock | ₩5.66 Billion | 6.54% |
| Other Components | ₩10.26 Billion | 11.84% |
| Total Equity | ₩86.65 Billion | 100.00% |
DRGEM Corporation Competitors by Market Cap
The table below lists competitors of DRGEM Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NextNRG Inc.
NASDAQ:NXXT
|
$42.61 Million |
|
Baltic Sea Properties AS
OL:BALT
|
$42.61 Million |
|
FOODWELL Co. Ltd
KQ:005670
|
$42.62 Million |
|
MBL Infrastructure Limited
NSE:MBLINFRA
|
$42.62 Million |
|
Prestige Wealth Inc.
NASDAQ:AURE
|
$42.60 Million |
|
Prodways Group SA
PA:PWG
|
$42.59 Million |
|
Mastermyne Group Ltd
AU:MYE
|
$42.59 Million |
|
reAlpha Tech Corp. Common Stock
NASDAQ:AIRE
|
$42.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DRGEM Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 79,320,915,580 to 86,645,972,620, a change of 7,325,057,040 (9.2%).
- Net income of 10,147,180,810 contributed positively to equity growth.
- Dividend payments of 1,982,984,580 reduced retained earnings.
- Share repurchases of 897,315,490 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩10.15 Billion | +11.71% |
| Dividends Paid | ₩1.98 Billion | -2.29% |
| Share Repurchases | ₩897.32 Million | -1.04% |
| Other Changes | ₩58.18 Million | +0.07% |
| Total Change | ₩- | 9.23% |
Book Value vs Market Value Analysis
This analysis compares DRGEM Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.73x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 5.64x to 0.73x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1022.94 | ₩5770.00 | x |
| 2017-12-31 | ₩1600.57 | ₩5770.00 | x |
| 2018-12-31 | ₩2532.12 | ₩5770.00 | x |
| 2019-12-31 | ₩2905.78 | ₩5770.00 | x |
| 2020-12-31 | ₩4693.61 | ₩5770.00 | x |
| 2021-12-31 | ₩5526.67 | ₩5770.00 | x |
| 2022-12-31 | ₩6683.85 | ₩5770.00 | x |
| 2023-12-31 | ₩7200.14 | ₩5770.00 | x |
| 2024-12-31 | ₩7952.44 | ₩5770.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DRGEM Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.71%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.76%
- • Asset Turnover: 0.85x
- • Equity Multiplier: 1.41x
- Recent ROE (11.71%) is below the historical average (23.87%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 75.21% | 5.11% | 1.36x | 10.80x | ₩1.42 Billion |
| 2016 | 3.49% | 0.94% | 1.27x | 2.92x | ₩-620.94 Million |
| 2017 | 25.50% | 8.09% | 1.43x | 2.20x | ₩2.43 Billion |
| 2018 | 16.23% | 8.22% | 1.22x | 1.61x | ₩1.79 Billion |
| 2019 | 16.82% | 9.10% | 0.95x | 1.94x | ₩2.22 Billion |
| 2020 | 38.05% | 18.75% | 1.47x | 1.38x | ₩14.73 Billion |
| 2021 | 20.58% | 14.64% | 1.02x | 1.38x | ₩6.45 Billion |
| 2022 | 19.55% | 13.06% | 0.87x | 1.72x | ₩7.03 Billion |
| 2023 | 11.59% | 8.14% | 0.88x | 1.62x | ₩1.26 Billion |
| 2024 | 11.71% | 9.76% | 0.85x | 1.41x | ₩1.48 Billion |
Industry Comparison
This section compares DRGEM Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $76,459,143,483
- Average return on equity (ROE) among peers: -8.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DRGEM Corporation (263690) | ₩89.26 Billion | 75.21% | 0.34x | $42.60 Million |
| Shinhung (004080) | $39.03 Billion | 19.75% | 1.29x | $88.50 Million |
| HansBiomed Corporation (042520) | $43.16 Billion | 11.38% | 0.21x | $262.71 Million |
| JVM Co. Ltd (054950) | $202.34 Billion | 14.26% | 0.41x | $194.75 Million |
| Huvitz Co. Ltd (065510) | $68.86 Billion | 9.49% | 0.66x | $56.91 Million |
| Vieworks Co. Ltd (100120) | $170.25 Billion | 13.45% | 0.16x | $166.59 Million |
| Corentec Co Ltd (104540) | $24.09 Billion | -123.57% | 1.67x | $50.95 Million |
| Humasis Co. Ltd (205470) | $16.13 Billion | -5.29% | 1.13x | $61.42 Million |
| NH SPAC 2 (206640) | $67.87 Billion | -3.16% | 0.59x | $167.83 Million |
| Hana Must SPAC 2 (208370) | $60.10 Billion | 8.60% | 0.11x | $74.07 Million |
| DRTECH Corporation (214680) | $72.77 Billion | -26.51% | 1.46x | $95.65 Million |
About DRGEM Corporation
DRGEM Corporation manufactures and sells diagnostic radiography systems. It offers high frequency X-ray generators; conventional and digital radiography systems; and ACQUIDR, a digital imaging system. DRGEM Corporation exports its products. The company was founded in 2003 and is headquartered in Gwangmyeong-si, South Korea.